Bio-Rad Laboratories (BIO) Short-term Investments (2009 - 2026)

Bio-Rad Laboratories (BIO) has reported Short-term Investments for 18 consecutive years, with $1.1 billion the latest figure, recorded in Q2 2026.

• On a quarterly basis, Short-term Investments rose 9.66% year-over-year to $1.1 billion in Q2 2026; TTM through Jun 2026 was $1.1 billion, a 9.66% increase from a year earlier, with the FY2025 full-year figure at $1.0 billion, down 14.07% from the prior year.
• Short-term Investments was $1.1 billion for Q2 2026 at Bio-Rad Laboratories, up from $1.1 billion in the prior quarter.
• Over five years, Short-term Investments peaked at $1.4 billion in Q1 2023 and troughed at $1.0 billion in Q2 2025.
• A 5-year average of $1.2 billion and a median of $1.2 billion in 2024 frame the typical range for Short-term Investments.
• Across the five-year window, Short-term Investments soared 266.97% in 2022 and fell 16.93% in 2025, its largest moves.
• Over 5 years, Short-term Investments stood at $1.4 billion in 2022, then declined by 11.29% to $1.2 billion in 2023, then retreated by 2.24% to $1.2 billion in 2024, then fell by 14.07% to $1.0 billion in 2025, then rose by 8.96% to $1.1 billion in 2026.
• The last three Short-term Investments figures came in at $1.1 billion (Q2 2026), $1.1 billion (Q1 2026), and $1.0 billion (Q4 2025), per Business Quant data.